Q2FY20 result highlight
Key positives: Strong revenue growth led by CSM business
Key negatives: Weak domestic business performance, higher depreciation costs
Impact on financials: Cut EPS by 3.8% in FY20E to factor in higher depreciation cost and increase EPS by 4.6% in FY21E factoring in Isagro Asia acquisition and strong growth outlook
Valuations & view
PI’s performance has been improving significantly on the back of strong volume growth in the CSM business. However domestic sales were adversely impacted due to erratic monsoons. Going forward management remains upbeat for CSM business growth outlook despite challenging global environment and expects recovery in the domestic business with favourable reservoir levels boosting prospects for Rabi. In the near term, PI’s strong order book position (~USD1.4bn) backed up with a rapidly expanding pipeline of pre-commercialization projects will drive sustained growth in the CSM business. Differentiated product offerings boost up prospects for the domestic business. Moreover recently announced bolt-on acquisition of Isagro Asia seems to be a good strategic fit for PI’s business and should augment growth prospects for both CSM as well as domestic business. We maintain our outperformer recommendation considering the long term prospects of PI’s innovation led business model with target price of Rs1,473 (30x FY21E EPS)
PI Industries Limited is a holding company. The Company is engaged in the manufacturing and distribution of agro chemicals. Its geographical segments include Sales within India and Sales outside India. The Company manufactures agrochemicals, plant nutrients and plant protection, specialty fertilizers and hybrid seeds. It offers insecticides under various brands, including LEPIDO, DODGER, COLT, OSHEEN, COLFOS, FOSMITE, JUMBO, FORATOX, CARINA, MAXIMA and VIBRANT. The Company offers fungicides under brands, which include CUPRINA, LURIT, KITAZIN, SANIPEB, CLUTCH and LOGIK. It offers herbicides under the brands, including SOLARO, NOMINEE GOLD, INRO, BINGO, PIMIX, BUNKER and MELSA. Its specialty products include BIOVITA Granules and BIOVITA Liquid. The Company provides services in various areas, including contract research, process development, analytical method development, process safety data generation and process detailed engineering.
IDFC Securities Ltd., a subsidiary of the Infrastructure Development Finance Company (IDFC) wherein the Government of India holds a 20% interest, is India's leading equities broker catering to most of the prominent financial institutions, both foreign and domestic investing in Indian equities. A research team of experienced and dedicated experts ensures the flow of critically investigated stock ideas and portfolio strategies for our clients. Our coverage spans across various growth sectors such as agriculture, automobiles, Consumer Goods, Technology, Healthcare, Infrastructure, Media, Power, Real Estate, Telecom, Capital Goods, Logistics, Cement amongst other sectors. Our clients value us for our strong research-led investment ideas, superior client servicing track record and exceptional execution skills.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.